Literature DB >> 3902272

Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli.

L B Hinshaw, B K Beller, A C Chang, C K Murray, D J Flournoy, R B Passey, L T Archer.   

Abstract

Adrenalectomized animals are extremely sensitive to endotoxin and die quickly when given small doses. A six hour administration of the corticosteroid, methylprednisolone sodium succinate (MPSS), combined with the antibiotic, gentamicin sulfate (GS), promotes complete recovery of dogs with intact adrenals administered LD100 E. coli. The aim of the present study was to determine if this early administered treatment would protect adrenalectomized dogs from overwhelming lethal doses of E. coli. Dogs were infused with MPSS from fifteen minutes to six hours after the onset of E. coli administration and with GS after administration of all E. coli. Animals given only E. coli died in 2.6 (+/- 0.3) hours, while those given no E. coli, or E. coli plus steroid/antibiotic, survived longer than 100 hours. Arterial pressure, pH, pO2, hematocrit, lactate, and glucose concentrations were maintained near control values in animals receiving steroid/antibiotic infusions. Adrenalectomized dogs infused with corticosteroid/antibiotic recovered completely from shock even though the treatment period was limited to the first 6 hours after lethal E. coli infusion. Findings indicate that animals treated with MPSS/GS after E. coli ultimately succumbed to adrenal insufficiency rather than from the E. coli insult and thus recovery from shock itself was complete.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902272

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  10 in total

1.  A prospective multicenter study of adrenal function in critically ill children.

Authors:  Kusum Menon; Roxanne E Ward; Margaret L Lawson; Isabelle Gaboury; James S Hutchison; Paul C Hébert
Journal:  Am J Respir Crit Care Med       Date:  2010-03-18       Impact factor: 21.405

2.  Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve.

Authors:  D Annane; E Bellissant; V Sebille; O Lesieur; B Mathieu; J C Raphael; P Gajdos
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

3.  Changes of inflammation and apoptosis in adrenal gland after experimental injury in rats with acute necrotizing pancreatitis.

Authors:  Jia Yu; Sheng Xu; Wei-Xing Wang; Wen-Hong Deng; Hao Jin; Xiao-Yan Chen; Chen Chen; Hai-Tao Sun
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

4.  Hydrocortisone Therapy in Catecholamine-Resistant Pediatric Septic Shock: A Pragmatic Analysis of Clinician Practice and Association With Outcomes.

Authors:  Blake Nichols; Sherri Kubis; Jennifer Hewlett; Nadir Yehya; Vijay Srinivasan
Journal:  Pediatr Crit Care Med       Date:  2017-09       Impact factor: 3.624

Review 5.  What is the rationale for hydrocortisone treatment in children with infection-related adrenal insufficiency and septic shock?

Authors:  Rajesh Aneja; Joseph A Carcillo
Journal:  Arch Dis Child       Date:  2006-09-26       Impact factor: 3.791

6.  The hepatoadrenal syndrome: a common yet unrecognized clinical condition.

Authors:  Paul E Marik; Timothy Gayowski; Thomas E Starzl
Journal:  Crit Care Med       Date:  2005-06       Impact factor: 7.598

7.  Central neural distribution of immunoreactive Fos and CRH in relation to plasma ACTH and corticosterone during sepsis in the rat.

Authors:  Drew E Carlson; William C Chiu; Suzelle M Fiedler; Gloria E Hoffman
Journal:  Exp Neurol       Date:  2007-03-23       Impact factor: 5.330

8.  Evidence of altered cortisol metabolism in critically ill patients: a prospective study.

Authors:  Bala Venkatesh; Jeremy Cohen; Ingrid Hickman; Janelle Nisbet; Peter Thomas; Gregory Ward; Jonathan Hall; John Prins
Journal:  Intensive Care Med       Date:  2007-06-09       Impact factor: 17.440

9.  Steroids in fluid and/or vasoactive infusion dependent pediatric shock: study protocol for a randomized controlled trial.

Authors:  Katharine O'Hearn; Dayre McNally; Karen Choong; Anand Acharya; Hector R Wong; Margaret Lawson; Tim Ramsay; Lauralyn McIntyre; Elaine Gilfoyle; Marisa Tucci; David Wensley; Ronald Gottesman; Gavin Morrison; Kusum Menon
Journal:  Trials       Date:  2016-05-06       Impact factor: 2.279

10.  Septic serum induces glucocorticoid resistance and modifies the expression of glucocorticoid isoforms receptors: a prospective cohort study and in vitro experimental assay.

Authors:  Julia Guerrero; Héctor A Gatica; Margarita Rodríguez; Roberto Estay; Irmgadt Annelise Goecke
Journal:  Crit Care       Date:  2013-06-12       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.